NEU 2.81% $18.65 neuren pharmaceuticals limited

TROFINETIDE TRIALS UPDATE, page-167

  1. 5,895 Posts.
    lightbulb Created with Sketch. 17648
    In Neuren’s previous Phase 2 trials of trofinetide, the paediatric Rett trial took just over 7 weeks from completion to report, the adult Rett trial also took just over 7 weeks to report and it took almost 10 weeks to announcement of results from the trial of trofinetide in Fragile X.

    Just 5 weeks have passed since completion of the Phase 3 Lavender trial....
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.